1. Home
  2. MDV vs MDWD Comparison

MDV vs MDWD Comparison

Compare MDV & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Modiv Industrial Inc. Class C

MDV

Modiv Industrial Inc. Class C

HOLD

Current Price

$18.00

Market Cap

187.5M

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$14.07

Market Cap

181.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDV
MDWD
Founded
2015
2000
Country
United States
Israel
Employees
9
N/A
Industry
Transportation Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.5M
181.1M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
MDV
MDWD
Price
$18.00
$14.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$18.00
$36.00
AVG Volume (30 Days)
55.5K
114.6K
Earning Date
05-08-2026
05-20-2026
Dividend Yield
7.50%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$48.92
Revenue Next Year
$8.56
$35.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.80
$13.54
52 Week High
$18.83
$21.26

Technical Indicators

Market Signals
Indicator
MDV
MDWD
Relative Strength Index (RSI) 50.81 41.34
Support Level $17.60 $13.54
Resistance Level $18.75 $14.99
Average True Range (ATR) 0.37 0.52
MACD -0.13 0.08
Stochastic Oscillator 30.33 35.98

Price Performance

Historical Comparison
MDV
MDWD

About MDV Modiv Industrial Inc. Class C

Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in, and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from the company's consolidated real estate properties.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: